Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

2.0K
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
2.0K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

415
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

212
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
212
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

2.8K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards harmonized global approaches to NORM regulation: review of practices and policy perspectives.

Radiation and environmental biophysics·2026
Same author

Awareness, Knowledge, and Uptake of the Human Papillomavirus (HPV) Vaccine Among Female Adolescents in the Rural Sonipat District of Haryana, India.

Cureus·2025
Same author

Resistance genes against yellow rust pathogen in <i>Triticum spelta</i>: a possible new <i>Yr</i> resistance gene in accession IARI276 and <i>Yr5</i> presence confirmed in PI348764.

Genome·2025
Same author

Harnessing the power of hybrid deep learning algorithm for the estimation of global horizontal irradiance.

The Science of the total environment·2024
Same author

Reproductive Risk Factors Associated with Female Infertility in Sonepat District of Haryana: A Community Based Cross-Sectional Study.

Journal of human reproductive sciences·2023
Same author

Association of Different Biochemical and Hemodynamic Characteristic with Type 2 Diabetes Mellitus and Hypertension in Nephrolithiasis Patients.

Kathmandu University medical journal (KUMJ)·2023

Related Experiment Video

Updated: May 4, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

1.8K

Intravenous iron in postpartum anemia.

Geeta Jain1, Urmila Palaria2, S K Jha3

  • 1Department of O&G, Govt. Medical College, Haldwani, Rampur Road, Haldwani, Uttarakhand India.

Journal of Obstetrics and Gynaecology of India
|January 17, 2014
PubMed
Summary
This summary is machine-generated.

Intravenous iron-sucrose rapidly increases hemoglobin levels in postpartum anemia compared to oral ferrous fumarate. This study found IV iron-sucrose to be more effective for treating postpartum anemia.

Keywords:
Iron–sucrosePostpartum anemia

More Related Videos

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.9K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.0K

Related Experiment Videos

Last Updated: May 4, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

1.8K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.9K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.0K

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Pharmacology

Background:

  • Postpartum anemia is a common complication affecting maternal health.
  • Oral iron supplementation is the standard treatment but can be slow to improve hemoglobin levels.

Purpose of the Study:

  • To compare the effectiveness of intravenous iron-sucrose versus oral ferrous fumarate in treating postpartum anemia.
  • To evaluate the rate of hemoglobin increase in women with postpartum anemia receiving different iron formulations.

Main Methods:

  • A randomized study involving 40 women with postpartum anemia (hemoglobin < 8 g/dl).
  • Group I received intravenous iron-sucrose (300-600 mg) over 3 days.
  • Group II received oral ferrous fumarate (300 mg daily) for 14 days.

Main Results:

  • Intravenous iron-sucrose group showed a mean hemoglobin increase of 2.4 g/dl by day 14.
  • Oral ferrous fumarate group showed a mean hemoglobin increase of 1.2 g/dl by day 14.
  • Significantly higher mean hemoglobin values were observed in the IV iron-sucrose group on days 7 and 14 (p < 0.001).

Conclusions:

  • Intravenous iron-sucrose is a more effective and rapid treatment for postpartum anemia compared to oral ferrous fumarate.
  • Intravenous iron-sucrose administration led to a faster increase in hemoglobin levels without serious adverse events.